Abiopharma

🔍 Herpin Mark C (Executive)

Company: HOME BANCORP, INC. (HBCP)

Report Date: 2026-06-12

Detailed Transactions and Holdings:

• Sold 110 shares of Common Stock at $68.08 per share (Direct)
  Date: 2026-06-12 | Code: F | equity_swap_involved: 0 | shares_owned_after: 4,729.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-12 | Code: H | nature_of_ownership: By ESOP | shares_owned_after: 93.86

Footnotes:

• F1: Includes the grant of 1,640 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2026 and that may be settled only in shares of the Issuer's common
• F2: Includes the grant of 1400 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2027 and that may be settled only in shares of the Issuer's common stock.
• F3: Includes the grant of 2,000 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on June 12, 2025 and that may be settled only in shares of the Issuer's common